Coloplast Statistics
Total Valuation
Coloplast has a market cap or net worth of 14.09 billion. The enterprise value is 17.72 billion.
| Market Cap | 14.09B |
| Enterprise Value | 17.72B |
Important Dates
The last earnings date was Tuesday, May 12, 2026.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | Dec 8, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 5.33% |
| Owned by Institutions (%) | 22.72% |
| Float | 143.38M |
Valuation Ratios
The trailing PE ratio is 43.37 and the forward PE ratio is 15.63.
| PE Ratio | 43.37 |
| Forward PE | 15.63 |
| PS Ratio | 3.26 |
| PB Ratio | 7.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.05 |
| P/OCF Ratio | 12.03 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.58, with an EV/FCF ratio of 18.92.
| EV / Earnings | 54.55 |
| EV / Sales | 4.03 |
| EV / EBITDA | 9.58 |
| EV / EBIT | 14.90 |
| EV / FCF | 18.92 |
Financial Position
The company has a current ratio of 1.75, with a Debt / Equity ratio of 1.89.
| Current Ratio | 1.75 |
| Quick Ratio | 1.01 |
| Debt / Equity | 1.89 |
| Debt / EBITDA | 2.05 |
| Debt / FCF | 3.99 |
| Interest Coverage | 11.64 |
Financial Efficiency
Return on equity (ROE) is 14.14% and return on invested capital (ROIC) is 12.58%.
| Return on Equity (ROE) | 14.14% |
| Return on Assets (ROA) | 9.90% |
| Return on Invested Capital (ROIC) | 12.58% |
| Return on Capital Employed (ROCE) | 18.66% |
| Weighted Average Cost of Capital (WACC) | 5.89% |
| Revenue Per Employee | 253,262 |
| Profits Per Employee | 19,018 |
| Employee Count | 16,983 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.36 |
Taxes
In the past 12 months, Coloplast has paid 206.41 million in taxes.
| Income Tax | 206.41M |
| Effective Tax Rate | 38.85% |
Stock Price Statistics
The stock price has decreased by -35.63% in the last 52 weeks. The beta is 0.50, so Coloplast's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -35.63% |
| 50-Day Moving Average | 6.64 |
| 200-Day Moving Average | 8.32 |
| Relative Strength Index (RSI) | 36.17 |
| Average Volume (20 Days) | 518,603 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Coloplast had revenue of 4.33 billion and earned 324.89 million in profits. Earnings per share was 1.44.
| Revenue | 4.33B |
| Gross Profit | 2.92B |
| Operating Income | 1.17B |
| Pretax Income | 531.30M |
| Net Income | 324.89M |
| EBITDA | 1.78B |
| EBIT | 1.17B |
| Earnings Per Share (EPS) | 1.44 |
Balance Sheet
The company has 164.61 million in cash and 3.74 billion in debt, with a net cash position of -3.57 billion.
| Cash & Cash Equivalents | 164.61M |
| Total Debt | 3.74B |
| Net Cash | -3.57B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.98B |
| Book Value Per Share | 8.80 |
| Working Capital | 690.20M |
Cash Flow
In the last 12 months, operating cash flow was 1.17 billion and capital expenditures -235.11 million, giving a free cash flow of 936.57 million.
| Operating Cash Flow | 1.17B |
| Capital Expenditures | -235.11M |
| Depreciation & Amortization | 611.51M |
| Net Borrowing | -34.22M |
| Free Cash Flow | 936.57M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.46%, with operating and profit margins of 27.05% and 7.51%.
| Gross Margin | 67.46% |
| Operating Margin | 27.05% |
| Pretax Margin | 12.28% |
| Profit Margin | 7.51% |
| EBITDA Margin | 41.07% |
| EBIT Margin | 27.05% |
| FCF Margin | 21.65% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 3.52%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 3.52% |
| Dividend Growth (YoY) | 7.27% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 246.15% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.52% |
| Earnings Yield | 2.31% |
| FCF Yield | 6.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Coloplast has an Altman Z-Score of 4.01 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.01 |
| Piotroski F-Score | 6 |